Stericycle (NASDAQ:SRCL) Coverage Initiated by Analysts at StockNews.com

Analysts at StockNews.com assumed coverage on shares of Stericycle (NASDAQ:SRCL) in a research report issued to clients and investors on Wednesday. The firm set a “hold” rating on the business services provider’s stock.

Several other equities research analysts have also weighed in on the company. Truist Financial boosted their target price on Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a report on Tuesday, June 4th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $62.00 price objective (down from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. Finally, Keefe, Bruyette & Woods lifted their target price on shares of Stericycle from $135.00 to $142.00 and gave the stock an “outperform” rating in a report on Tuesday, June 4th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, Stericycle presently has an average rating of “Hold” and an average target price of $74.00.

Stericycle Stock Performance

Shares of SRCL opened at $61.71 on Wednesday. The firm has a market cap of $5.73 billion, a price-to-earnings ratio of -280.50, a price-to-earnings-growth ratio of 3.37 and a beta of 1.11. The company’s fifty day moving average is $59.47 and its 200-day moving average is $54.99. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.55. Stericycle has a 12 month low of $37.78 and a 12 month high of $61.77.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.57 by $0.04. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. The firm had revenue of $661.60 million during the quarter, compared to analysts’ expectations of $672.07 million. Equities analysts expect that Stericycle will post 2.29 EPS for the current fiscal year.

Institutional Trading of Stericycle

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Clearstead Trust LLC acquired a new stake in Stericycle during the first quarter worth $25,000. GAMMA Investing LLC lifted its stake in Stericycle by 170.9% during the first quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock worth $43,000 after purchasing an additional 516 shares during the period. TFO Wealth Partners LLC lifted its stake in Stericycle by 22,325.0% during the fourth quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock worth $44,000 after purchasing an additional 893 shares during the period. Headlands Technologies LLC acquired a new stake in Stericycle during the first quarter valued at approximately $44,000. Finally, International Assets Investment Management LLC bought a new stake in shares of Stericycle in the 2nd quarter valued at approximately $45,000. 98.82% of the stock is currently owned by institutional investors and hedge funds.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.